Bioengineer Gang Bao uses gene editing to repair up to 40 percent of bone marrow cells from patients
Scientists have successfully used gene editing to repair 20 to 40 percent of stem and progenitor cells taken from the peripheral blood of patients with sickle cell disease, according to Rice University bioengineer Gang Bao.
Bao, in collaboration with Baylor College of Medicine, Texas Children’s Hospital and Stanford University, is working to find a cure for the hereditary disease. A single DNA mutation causes the body to make sticky, crescent-shaped red blood cells that contain abnormal hemoglobin and can block blood flow in limbs and organs.
In his talk at the annual American Association for the Advancement of Science meeting in Austin Feb. 16, Bao revealed results from a series of tests to see whether CRISPR/Cas9-based editing can fix the mutation. His presentation was part of a scientific session titled “Gene Editing and Human Identity: Promising Advances and Ethical Challenges.”
“Sickle cell disease is caused by a single mutation in the beta-globin gene (in the stem cell’s DNA),” he said. “The idea is to correct that particular mutation, and then stem cells that have the correction would differentiate into normal blood cells, including red blood cells. Those will then be healthy blood cells.”
Bao’s lab collaborated with Vivien Sheehan, an assistant professor of pediatrics and hematology at Baylor and a member of the sickle cell program at Texas Children’s, to collect stem and progenitor cells (CD34-positive cells) from patients with the disease. These were then edited in the Bao lab with CRISPR/Cas9 together with a custom template, a piece of DNA designed to correct the mutation.
The gene-edited cells were injected into the bone marrow of immunodeficient mice and tested after 19 weeks to see how many retained the edit. “The rate of repair remained stable, which is great,” Bao said. This engraftment study was carried out in the lab of Matt Porteus, an associate professor of pediatrics at Stanford.
Another major finding of the study is that the CRISPR/Cas9 system could introduce large alterations to the genes in patients’ cells, in addition to small mutations or deletions. These off-target effects could cause a disease.
The findings, part of an upcoming paper, are a step toward treating sickle cell disease. Obstacles in the way of a cure include optimizing the CRISPR/Cas9 system to eliminate off-target effects, as well as finding a way to further increase the amount of gene-corrected stem cells.
Bao pointed out that researchers still don’t know whether repairing as much as 40 percent of the cells is enough to cure a patient. “We’d like to say, ‘Yes,’” he said, “but we don’t really know yet. That’s something we hope to learn from an eventual clinical trial.”
The Latest on: Sickle cell disease
- Santa Brings Joy To Sickle-Cell Families: Photos Of Week on December 14, 2018 at 11:59 am
OAKLAND, CA – Despite his North Pole duties, Santa Claus made time last week to attend a holiday party at the West Oakland Youth Center in Oakland with families battling sickle-cell disease. […]
- Can gene therapy offer a cure for sickle-cell disease? on December 14, 2018 at 5:56 am
[I]n November, six months after [21-year-old Manny] Johnson became the first patient to receive an experimental therapy aimed at curing his [sickle cell] disease, the port that had become part of ... […]
- Sickle Cell Treatment Act of 2018 Passed in Congress, Now Awaits President’s Signature on December 13, 2018 at 6:49 am
On December 10, 2018, S.2465 – The Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018 – was passed by the Congress and now ... […]
- Gene therapies could transform sickle cell disease into a curable illness on December 13, 2018 at 6:28 am
Manny Johnson keeps catching himself rubbing a spot on the upper right side of his chest. Starting when he was a teenager, the 21-year-old from Boston depended on a port implanted there to ease his mo... […]
- Bipartisan Support: Senators Cory Booker and Tim Scott just got a law passed to help fight sickle cell disease on December 12, 2018 at 4:54 pm
The blood disorder disproportionately impacts African-Americans. Ninety percent of those who are diagnosed with sickle cell are African-American. Sickle cell anemia is group of blood disorders ... […]
- Sickle Cell Disease market research for 2018 available in new report on December 12, 2018 at 6:13 am
The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication. The global Sickle Cell ... […]
- New Sickle Cell Test Can Transform Screening on December 10, 2018 at 11:11 am
Sickle cell disease is common throughout much of sub-Saharan Africa. It affects up to 3% of births in some areas and is associated with very high mortality. Many cases go undiagnosed in regions where ... […]
- Clinical Challenges: Sickle Cell Management in the ED on December 6, 2018 at 8:03 am
The most common complication of sickle cell disease (SCD) is a vaso-occlusive crisis. The sudden nature of these crises, marked by intermittent, unexpected episodes of severe pain, leads most SCD pati... […]
- Inexpensive sickle cell diagnostic tool shows perfect accuracy in Uganda on December 4, 2018 at 4:27 pm
SAN DIEGO — An inexpensive, easy-to-use diagnostic tool for sickle cell disease showed 100% accuracy among a large cohort of children from Uganda, according to findings presented during the late-break... […]
- $2 Test Could Transform Sickle Cell Dx in Africa on December 4, 2018 at 7:39 am
SAN DIEGO -- An inexpensive, easy-to-use blood test could dramatically alter how sickle cell disease is diagnosed in Africa, where the often-undiagnosed disease is a leading cause of childhood mortali... […]
via Google News and Bing News